![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 11, 9142-9149, March 14, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Pediatrics, University of Texas Southwestern
Medical Center, Dallas, Texas 75390 and the § Diabetes Unit,
Laboratory of Clinical Investigation, NCCAM, National Institutes of
Health, Bethesda, Maryland 20892-1755
High density lipoprotein (HDL) activates
endothelial nitric-oxide synthase (eNOS), leading to increased
production of the antiatherogenic molecule NO. A variety of stimuli
regulate eNOS activity through signaling pathways involving Akt kinase
and/or mitogen-activated protein (MAP) kinase. In the present study, we
investigated the role of kinase cascades in HDL-induced eNOS stimulation in cultured endothelial cells and COS M6 cells transfected with eNOS and the HDL receptor, scavenger receptor B-I. HDL
(10-50 µg/ml, 20 min) caused eNOS phosphorylation at Ser-1179, and
dominant negative Akt inhibited both HDL-mediated phosphorylation and
activation of the enzyme. Phosphoinositide 3-kinase (PI3 kinase)
inhibition or dominant negative PI3 kinase also blocked the
phosphorylation and activation of eNOS by HDL. Studies with genistein
and PP2 showed that the nonreceptor tyrosine kinase, Src, is an
upstream stimulator of the PI3 kinase-Akt pathway in this paradigm. In addition, HDL activated MAP kinase through PI3 kinase, and
mitogen-activated protein kinase/extracellular signal-regulated kinase
kinase inhibition fully attenuated eNOS stimulation by HDL without
affecting Akt or eNOS Ser-1179 phosphorylation. Conversely, dominant
negative Akt did not alter HDL-induced MAP kinase activation. These
results indicate that HDL stimulates eNOS through common upstream,
Src-mediated signaling, which leads to parallel activation of Akt and
MAP kinases and their resultant independent modulation of the enzyme.
High Density Lipoprotein-induced Endothelial Nitric-oxide
Synthase Activation Is Mediated by Akt and MAP Kinases*
,
*
This work was supported by the Scientist Development Program
of the American Heart Association (to C. M.) and National Institute of
Health Grants HL 58888, HL 53546, and HD 30276 (to P. W. S.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Pediatrics,
University of Texas Southwestern Medical Center, 5323 Harry Hines
Blvd., Dallas, TX 75390. Tel.: 214-648-4574; Fax: 214-648-2481; E-mail:
chieko.mineo@utsouthwestern.edu.
This article has been cited by other articles:
![]() |
J.-Z. Sheng, F. Arshad, J. E. Braun, and A. P. Braun Estrogen and the Ca2+-mobilizing agonist ATP evoke acute NO synthesis via distinct pathways in an individual human vascular endothelium-derived cell Am J Physiol Cell Physiol, June 1, 2008; 294(6): C1531 - C1541. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Norata, P. Marchesi, A. Pirillo, P. Uboldi, G. Chiesa, V. Maina, C. Garlanda, A. Mantovani, and A. L. Catapano Long Pentraxin 3, a Key Component of Innate Immunity, Is Modulated by High-Density Lipoproteins in Endothelial Cells Arterioscler. Thromb. Vasc. Biol., May 1, 2008; 28(5): 925 - 931. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. T. Demchenko, D. N. Atochin, D. R. Gutsaeva, R. R. Godfrey, P. L. Huang, C. A. Piantadosi, and B. W. Allen Contributions of nitric oxide synthase isoforms to pulmonary oxygen toxicity, local vs. mediated effects Am J Physiol Lung Cell Mol Physiol, May 1, 2008; 294(5): L984 - L990. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Imaizumi, S.-i. Miura, K. Nakamura, Y. Kiya, Y. Uehara, B. Zhang, Y. Matsuo, H. Urata, M. Ideishi, K.-A. Rye, et al. Antiarrhythmogenic effect of reconstituted high-density lipoprotein against ischemia/reperfusion in rats. J. Am. Coll. Cardiol., April 22, 2008; 51(16): 1604 - 1612. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Van Linthout, F. Spillmann, A. Riad, C. Trimpert, J. Lievens, M. Meloni, F. Escher, E. Filenberg, O. Demir, J. Li, et al. Human Apolipoprotein A-I Gene Transfer Reduces the Development of Experimental Diabetic Cardiomyopathy Circulation, March 25, 2008; 117(12): 1563 - 1573. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhu, S. Saddar, D. Seetharam, K. L. Chambliss, C. Longoria, D. L. Silver, I. S. Yuhanna, P. W. Shaul, and C. Mineo The Scavenger Receptor Class B Type I Adaptor Protein PDZK1 Maintains Endothelial Monolayer Integrity Circ. Res., February 29, 2008; 102(4): 480 - 487. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Valiyaveettil, N. Kar, M. Z. Ashraf, T. V. Byzova, M. Febbraio, and E. A. Podrez Oxidized high-density lipoprotein inhibits platelet activation and aggregation via scavenger receptor BI Blood, February 15, 2008; 111(4): 1962 - 1971. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. White, T. Guerin, H. Swanson, S. Post, H. Zhu, M. Gong, J. Liu, W. V. Everson, X.-A. Li, G. A. Graf, et al. Diabetic HDL-associated myristic acid inhibits acetylcholine-induced nitric oxide generation by preventing the association of endothelial nitric oxide synthase with calmodulin Am J Physiol Cell Physiol, January 1, 2008; 294(1): C295 - C305. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Argraves and W. S. Argraves HDL serves as a S1P signaling platform mediating a multitude of cardiovascular effects J. Lipid Res., November 1, 2007; 48(11): 2325 - 2333. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Persegol, B. Verges, P. Gambert, and L. Duvillard Inability of HDL from abdominally obese subjects to counteract the inhibitory effect of oxidized LDL on vasorelaxation J. Lipid Res., June 1, 2007; 48(6): 1396 - 1401. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-a Kim, G. Formoso, Y. Li, M. A. Potenza, F. L. Marasciulo, M. Montagnani, and M. J. Quon Epigallocatechin Gallate, a Green Tea Polyphenol, Mediates NO-dependent Vasodilation Using Signaling Pathways in Vascular Endothelium Requiring Reactive Oxygen Species and Fyn J. Biol. Chem., May 4, 2007; 282(18): 13736 - 13745. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-M. Jaubert, N. Mehebik-Mojaat, D. Lacasa, D. Sabourault, Y. Giudicelli, and C. Ribiere Nongenomic Estrogen Effects on Nitric Oxide Synthase Activity in Rat Adipocytes Endocrinology, May 1, 2007; 148(5): 2444 - 2452. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Iantorno, H. Chen, J.-a Kim, M. Tesauro, D. Lauro, C. Cardillo, and M. J. Quon Ghrelin has novel vascular actions that mimic PI 3-kinase-dependent actions of insulin to stimulate production of NO from endothelial cells Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E756 - E764. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, A. M. Ahmed, N. McFarlane, C. Capone, D. R. Boreham, R. Truant, S. A. Igdoura, and B. L. Trigatti Regulation of SR-BI-mediated selective lipid uptake in Chinese hamster ovary-derived cells by protein kinase signaling pathways J. Lipid Res., February 1, 2007; 48(2): 405 - 416. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Kapadia, H. Barth, T. Baumert, J. A. McKeating, and F. V. Chisari Initiation of Hepatitis C Virus Infection Is Dependent on Cholesterol and Cooperativity between CD81 and Scavenger Receptor B Type I J. Virol., January 1, 2007; 81(1): 374 - 383. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. DeKroon, J. B. Robinette, A. B. Hjelmeland, E. Wiggins, M. Blackwell, M. Mihovilovic, M. Fujii, J. York, J. Hart, C. Kontos, et al. APOE4-VLDL Inhibits the HDL-Activated Phosphatidylinositol 3-Kinase/Akt Pathway via the Phosphoinositol Phosphatase SHIP2 Circ. Res., October 13, 2006; 99(8): 829 - 836. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Shetty, E. R.M. Eckhardt, S. R. Post, and D. R. van der Westhuyzen Phosphatidylinositol-3-Kinase Regulates Scavenger Receptor Class B Type I Subcellular Localization and Selective Lipid Uptake in Hepatocytes Arterioscler. Thromb. Vasc. Biol., September 1, 2006; 26(9): 2125 - 2131. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mineo, H. Deguchi, J. H. Griffin, and P. W. Shaul Endothelial and Antithrombotic Actions of HDL Circ. Res., June 9, 2006; 98(11): 1352 - 1364. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mineo and P. W. Shaul Circulating cardiovascular disease risk factors and signaling in endothelial cell caveolae Cardiovasc Res, April 1, 2006; 70(1): 31 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Seetharam, C. Mineo, A. K. Gormley, L. L. Gibson, W. Vongpatanasin, K. L. Chambliss, L. D. Hahner, M. L. Cummings, R. L. Kitchens, Y. L. Marcel, et al. High-Density Lipoprotein Promotes Endothelial Cell Migration and Reendothelialization via Scavenger Receptor-B Type I Circ. Res., January 6, 2006; 98(1): 63 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mineo, A. K. Gormley, I. S. Yuhanna, S. Osborne-Lawrence, L. L. Gibson, L. Hahner, R. V. Shohet, S. Black, J. E. Salmon, D. Samols, et al. Fc{gamma}RIIB Mediates C-Reactive Protein Inhibition of Endothelial NO Synthase Circ. Res., November 25, 2005; 97(11): 1124 - 1131. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Mehebik, A.-M. Jaubert, D. Sabourault, Y. Giudicelli, and C. Ribiere Leptin-induced nitric oxide production in white adipocytes is mediated through PKA and MAP kinase activation Am J Physiol Cell Physiol, August 1, 2005; 289(2): C379 - C387. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Norata, E. Callegari, M. Marchesi, G. Chiesa, P. Eriksson, and A. L. Catapano High-Density Lipoproteins Induce Transforming Growth Factor-{beta}2 Expression in Endothelial Cells Circulation, May 31, 2005; 111(21): 2805 - 2811. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-A. Li, L. Guo, J. L. Dressman, R. Asmis, and E. J. Smart A Novel Ligand-independent Apoptotic Pathway Induced by Scavenger Receptor Class B, Type I and Suppressed by Endothelial Nitric-oxide Synthase and High Density Lipoprotein J. Biol. Chem., May 13, 2005; 280(19): 19087 - 19096. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Xu, S.-S. Park, R. A. Mueller, R. C. Bagnell, C. Patterson, and P. G. Boysen Adenosine produces nitric oxide and prevents mitochondrial oxidant damage in rat cardiomyocytes Cardiovasc Res, March 1, 2005; 65(4): 803 - 812. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Chambliss, L. Simon, I. S. Yuhanna, C. Mineo, and P. W. Shaul Dissecting the Basis of Nongenomic Activation of Endothelial Nitric Oxide Synthase by Estradiol: Role of ER{alpha} Domains with Known Nuclear Functions Mol. Endocrinol., February 1, 2005; 19(2): 277 - 289. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Levkau, S. Hermann, G. Theilmeier, M. van der Giet, J. Chun, O. Schober, and M. Schafers High-Density Lipoprotein Stimulates Myocardial Perfusion In Vivo Circulation, November 23, 2004; 110(21): 3355 - 3359. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Anter, S. R. Thomas, E. Schulz, O. M. Shapira, J. A. Vita, and J. F. Keaney Jr. Activation of Endothelial Nitric-oxide Synthase by the p38 MAPK in Response to Black Tea Polyphenols J. Biol. Chem., November 5, 2004; 279(45): 46637 - 46643. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Chikani, W. Zhu, and E. J. Smart Lipids: potential regulators of nitric oxide generation Am J Physiol Endocrinol Metab, September 1, 2004; 287(3): E386 - E389. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Ashton and J. A. Ware Thromboxane A2 Receptor Signaling Inhibits Vascular Endothelial Growth Factor-Induced Endothelial Cell Differentiation and Migration Circ. Res., August 20, 2004; 95(4): 372 - 379. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-W. Xu, K. Ikeda, and Y. Yamori Upregulation of Endothelial Nitric Oxide Synthase by Cyanidin-3-Glucoside, a Typical Anthocyanin Pigment Hypertension, August 1, 2004; 44(2): 217 - 222. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. G. Drew, N. H. Fidge, G. Gallon-Beaumier, B. E. Kemp, and B. A. Kingwell High-density lipoprotein and apolipoprotein AI increase endothelial NO synthase activity by protein association and multisite phosphorylation PNAS, May 4, 2004; 101(18): 6999 - 7004. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Viswambharan, X.-F. Ming, S. Zhu, A. Hubsch, P. Lerch, G. Vergeres, S. Rusconi, and Z. Yang Reconstituted High-Density Lipoprotein Inhibits Thrombin-Induced Endothelial Tissue Factor Expression Through Inhibition of RhoA and Stimulation of Phosphatidylinositol 3-Kinase but not Akt/Endothelial Nitric Oxide Synthase Circ. Res., April 16, 2004; 94(7): 918 - 925. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Zhang, J. Cheng, N. R. Hackett, G. Lam, K. Shido, R. Pergolizzi, D. K. Jin, R. G. Crystal, and S. Rafii Adenovirus E4 Gene Promotes Selective Endothelial Cell Survival and Angiogenesis via Activation of the Vascular Endothelial-Cadherin/Akt Signaling Pathway J. Biol. Chem., March 19, 2004; 279(12): 11760 - 11766. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lorenz, S. Wessler, E. Follmann, W. Michaelis, T. Dusterhoft, G. Baumann, K. Stangl, and V. Stangl A Constituent of Green Tea, Epigallocatechin-3-gallate, Activates Endothelial Nitric Oxide Synthase by a Phosphatidylinositol-3-OH-kinase-, cAMP-dependent Protein Kinase-, and Akt-dependent Pathway and Leads to Endothelial-dependent Vasorelaxation J. Biol. Chem., February 13, 2004; 279(7): 6190 - 6195. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-H. Cho, Y. J. Choi, S. A. Jo, and I. Jo Nitric Oxide Production and Regulation of Endothelial Nitric-oxide Synthase Phosphorylation by Prolonged Treatment with Troglitazone: EVIDENCE FOR INVOLVEMENT OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) {gamma}-DEPENDENT AND PPAR{gamma}-INDEPENDENT SIGNALING PATHWAYS J. Biol. Chem., January 23, 2004; 279(4): 2499 - 2506. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Calabresi, M. Gomaraschi, and G. Franceschini Endothelial Protection by High-Density Lipoproteins: From Bench to Bedside Arterioscler. Thromb. Vasc. Biol., October 1, 2003; 23(10): 1724 - 1731. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |